Impulse (Qingdao) Health Tech Co.,Ltd. (SHE:002899)
China · Delayed Price · Currency is CNY 19.91
+0.03 (0.15%)
Sep 16, 2026, 3:04 PM CST
SHE:002899 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,196 | 1,169 | 1,210 | 893.5 | 822.39 | 862.15 |
Other Revenue | 4.42 | 6.42 | 3.57 | 1.82 | 2.31 | 2.24 |
| 1,201 | 1,176 | 1,214 | 895.32 | 824.7 | 864.39 | |
Revenue Growth | -1.30% | -3.13% | 35.58% | 8.56% | -4.59% | -0.41% |
Cost of Revenue | 898.59 | 866.11 | 839.04 | 620.5 | 623.01 | 649.95 |
Gross Profit | 302.11 | 309.8 | 374.81 | 274.82 | 201.68 | 214.45 |
Selling, General & Admin | 165.3 | 163.86 | 165.09 | 134.78 | 114.24 | 116.87 |
Research & Development | 47.64 | 51.57 | 52.55 | 41.09 | 39.89 | 46.61 |
Other Operating Expenses | 18.33 | 19.3 | 11.19 | 2.9 | -0.71 | 4.89 |
Operating Expenses | 235.87 | 234.57 | 250.16 | 191.28 | 170.88 | 179.26 |
Operating Income | 66.25 | 75.23 | 124.65 | 83.54 | 30.8 | 35.18 |
Interest Expense | -17.06 | -18.54 | -23.22 | -0.45 | -0.26 | -0.29 |
Interest & Investment Income | 9.47 | 11.12 | 14.2 | 12.81 | 4.55 | 6.73 |
Currency Exchange Gain (Loss) | -10.63 | -0.19 | 10.21 | 4.17 | 13.32 | -3.99 |
Other Non Operating Income (Expenses) | 0.91 | -0.39 | 0.55 | -0.43 | -0.71 | -2.16 |
EBT Excluding Unusual Items | 48.94 | 67.24 | 126.39 | 99.65 | 47.7 | 35.48 |
Impairment of Goodwill | -0.39 | -0.39 | - | - | - | - |
Gain (Loss) on Sale of Investments | 7.53 | 3.47 | -1.01 | 1.38 | 0.5 | - |
Gain (Loss) on Sale of Assets | - | - | -0.15 | -0.08 | 0.38 | -0.02 |
Asset Writedown | -0.44 | -0.48 | -2.92 | -0.44 | -2.91 | -0.01 |
Other Unusual Items | 3.54 | 1.51 | -0.19 | 0.7 | -0.25 | -17.96 |
Pretax Income | 59.18 | 71.34 | 122.12 | 101.2 | 45.43 | 17.49 |
Income Tax Expense | 4.37 | 8.36 | 13 | 13.04 | -20.24 | 0.06 |
Net Income | 54.8 | 62.99 | 109.12 | 88.16 | 65.66 | 17.43 |
Net Income to Common | 54.8 | 62.99 | 109.12 | 88.16 | 65.66 | 17.43 |
Net Income Growth | -38.86% | -42.27% | 23.77% | 34.26% | 276.69% | -55.94% |
Shares Outstanding (Basic) | 148 | 146 | 138 | 121 | 119 | 116 |
Shares Outstanding (Diluted) | 148 | 146 | 138 | 121 | 119 | 116 |
Shares Change | 1.19% | 6.05% | 14.37% | 1.16% | 2.73% | -3.06% |
EPS (Basic) | 0.37 | 0.43 | 0.79 | 0.73 | 0.55 | 0.15 |
EPS (Diluted) | 0.37 | 0.43 | 0.79 | 0.73 | 0.55 | 0.15 |
EPS Growth | -39.58% | -45.57% | 8.22% | 32.73% | 266.67% | -54.55% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -38.98 | 58.73 | 32.57 | -47.75 | -350.57 | -370.16 |
Free Cash Flow Per Share | -0.26 | 0.40 | 0.24 | -0.40 | -2.94 | -3.19 |
Dividend Per Share | 0.083 | 0.083 | 0.075 | 0.071 | 0.063 | 0.022 |
Dividend Growth | 10.67% | 10.67% | 5.63% | 12.70% | 186.36% | -43.59% |
Gross Margin | 25.16% | 26.35% | 30.88% | 30.70% | 24.45% | 24.81% |
Operating Margin | 5.52% | 6.40% | 10.27% | 9.33% | 3.74% | 4.07% |
Profit Margin | 4.56% | 5.36% | 8.99% | 9.85% | 7.96% | 2.02% |
Free Cash Flow Margin | -3.25% | 4.99% | 2.68% | -5.33% | -42.51% | -42.82% |
EBITDA | 150.14 | 156.61 | 181.32 | 102.14 | 52.77 | 58.19 |
EBITDA Margin | 12.50% | 13.32% | 14.94% | 11.41% | 6.40% | 6.73% |
D&A For EBITDA | 83.89 | 81.38 | 56.67 | 18.6 | 21.97 | 23.01 |
EBIT | 66.25 | 75.23 | 124.65 | 83.54 | 30.8 | 35.18 |
EBIT Margin | 5.52% | 6.40% | 10.27% | 9.33% | 3.74% | 4.07% |
Effective Tax Rate | 7.39% | 11.71% | 10.65% | 12.88% | - | 0.34% |
Revenue as Reported | 1,201 | 1,176 | 1,214 | 895.32 | 824.7 | 864.39 |
Advertising Expenses | - | 11.66 | 11.27 | 9.49 | 7.6 | 11.02 |